Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu
Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 - MRNS
12:20pm, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNS
12:20pm, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
12:00pm, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Investors in Marinus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights - MRNS
11:30am, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
An Inquiry Into Marinus Pharmaceuticals Inc Is Initiated By The Schall Law Firm And Affected Investors Are Urged To Connect
11:00am, Thursday, 04'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) - August 5, 2024 Deadline to Join - Contact Levi & Korsinsky
09:00am, Thursday, 04'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
NEW YORK , July 4, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all persons and entities that purch
Lost Money on Marinus Pharmaceuticals, Inc.(MRNS)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
08:40pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
08:30pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit
08:20pm, Wednesday, 03'rd Jul 2024
Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES , July 3, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substan
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 - MRNS
12:15pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
12:00pm, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu
